Cumberland Pharmaceuticals Inc (CPIX) stock
CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/30
$5.88−0.75 (-11.31%)
Close on Nov 13, 2026Market cap $88.10MP/E 1.3Yield –
Cumberland Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cumberland Pharmaceuticals's price to book ratio was 5.3× on Nov 11, 2026, against 1.3× a year earlier. Over the last 5 years it ranged from 0.6× to 6.7×, with a median of 1.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.3× | +3.0 |
| 2025 | Dec 31, 2025 | 2.3× | +0.9 |
| 2024 | Dec 31, 2024 | 1.3× | +0.6 |
| 2023 | Dec 29, 2023 | 0.7× | −0.1 |
| 2022 | Dec 30, 2022 | 0.8× | −0.6 |
| 2021 | Dec 31, 2021 | 1.5× | +0.6 |
| 2020 | Dec 31, 2020 | 0.9× | −0.6 |
| 2019 | Dec 31, 2019 | 1.5× | −0.1 |
| 2018 | Dec 31, 2018 | 1.6× | −0.2 |
| 2017 | Dec 29, 2017 | 1.8× | +0.6 |
| 2016 | Dec 30, 2016 | 1.2× | +0.0 |
| 2015 | Dec 31, 2015 | 1.1× | −0.1 |
| 2014 | Dec 31, 2014 | 1.3× | +0.1 |
| 2013 | Dec 31, 2013 | 1.1× | +0.2 |
| 2012 | Dec 31, 2012 | 1.0× | −0.3 |
| 2011 | Dec 30, 2011 | 1.3× | – |
See a number that looks wrong?